Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 4.99846 | 76 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 6.31359 | 84 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 6.14253 | 83 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 5.24489 | 76 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 5.14504 | 76 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 5.17467 | 78 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 5.37572 | 79 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 5.21894 | 77 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 5.15106 | 76 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.91564 | 74 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 5.67055 | 80 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 5.3403 | 77 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 5.04451 | 76 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 5.17274 | 77 |